Versant Ventures VII GP, L.P. — SEC insider filings

SEC reporting owner CIK 1777655. 11 insider filings on record with FilingPulse; latest filed 2026-10-28.

Transaction summary — filings shown

Covers all 11 filings on record, filed 2024-03-25 to 2026-10-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
LENZ Therapeutics, Inc. (LENZ)10% owner9—34 legs · 1,885,262 sh · $66,603,1391
Lycia Therapeutics, Inc. (LYCA)10% owner2——4

Insider filings — Versant Ventures VII GP, L.P.

FiledFormIssuerReported transactionsSource
2026-10-284Lycia Therapeutics, Inc. (LYCA)
jointly with Versant Venture Capital VII, L.P., Versant Ventures VII GP-GP, LLC, Versant Vantage II, L.P., Versant Vantage II GP, L.P., Versant Vantage II GP-GP, LLC
Conversion (C): 5,631,425 · Conversion (C): 1,393,882 · Conversion (C): 25,390,410 (derivative) · Conversion (C): 6,284,597 (derivative)EDGAR
2026-10-223Lycia Therapeutics, Inc. (LYCA)
jointly with Versant Venture Capital VII, L.P., Versant Ventures VII GP-GP, LLC, Versant Vantage II, L.P., Versant Vantage II GP, L.P., Versant Vantage II GP-GP, LLC
Holdings only — no transactions reportedEDGAR
2025-10-024LENZ Therapeutics, Inc. (LENZ)
jointly with Versant Venture Capital VI, L.P., Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage II, L.P., Versant Vantage II GP, L.P., Versant Vantage II GP-GP, LLC, Versant Venture Capital VII, L.P., Versant Ventures VII GP-GP, LLC
Sale (S): 49,701 @ $45.35 · Sale (S): 34,405 @ $45.35 · Sale (S): 83,066 @ $46.41 · Sale (S): 57,502 @ $46.41 · Sale (S): 177 @ $47.01 · Sale (S): 123 @ $47.01EDGAR
2025-09-224LENZ Therapeutics, Inc. (LENZ)
jointly with Versant Venture Capital VI, L.P., Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage II, L.P., Versant Vantage II GP, L.P., Versant Vantage II GP-GP, LLC, Versant Venture Capital VII, L.P., Versant Ventures VII GP-GP, LLC
Sale (S): 49,479 @ $41.59 · Sale (S): 24,370 @ $41.59 · Sale (S): 40,907 @ $43.00 · Sale (S): 20,148 @ $43.00 · Sale (S): 268 @ $43.30 · Sale (S): 132 @ $43.30EDGAR
2025-08-264LENZ Therapeutics, Inc. (LENZ)
jointly with Versant Venture Capital VI, L.P., Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage II, L.P., Versant Vantage II GP, L.P., Versant Vantage II GP-GP, LLC, Versant Venture Capital VII, L.P., Versant Ventures VII GP-GP, LLC
Sale (S): 20,493 @ $40.03 · Sale (S): 10,076 @ $40.03 · Sale (S): 5,668 @ $40.59 · Sale (S): 2,809 @ $40.59 · Sale (S): 50,270 @ $39.53 · Sale (S): 24,760 @ $39.53 · +6 moreEDGAR
2025-08-194LENZ Therapeutics, Inc. (LENZ)
jointly with Versant Venture Capital VI, L.P., Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage II, L.P., Versant Vantage II GP, L.P., Versant Vantage II GP-GP, LLC, Versant Venture Capital VII, L.P., Versant Ventures VII GP-GP, LLC
Sale (S): 145,051 @ $39.50 · Sale (S): 69,949 @ $39.50 · Sale (S): 30,628 @ $38.56 · Sale (S): 15,085 @ $38.56EDGAR
2025-07-144LENZ Therapeutics, Inc. (LENZ)
jointly with Versant Venture Capital VI, L.P., Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage II, L.P., Versant Vantage II GP, L.P., Versant Vantage II GP-GP, LLC, Versant Venture Capital VII, L.P., Versant Ventures VII GP-GP, LLC
Sale (S): 191,376 @ $34EDGAR
2025-07-014LENZ Therapeutics, Inc. (LENZ)
jointly with Versant Venture Capital VI, L.P., Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage II, L.P., Versant Vantage II GP, L.P., Versant Vantage II GP-GP, LLC, Versant Venture Capital VII, L.P., Versant Ventures VII GP-GP, LLC
Sale (S): 200,000 @ $30.46EDGAR
2025-06-204LENZ Therapeutics, Inc. (LENZ)
jointly with Versant Venture Capital VI, L.P., Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage II, L.P., Versant Vantage II GP, L.P., Versant Vantage II GP-GP, LLC, Versant Venture Capital VII, L.P., Versant Ventures VII GP-GP, LLC
Sale (S): 100,000 @ $29.95 · Sale (S): 100,877 @ $30.35 · Sale (S): 133,924 @ $30.25EDGAR
2025-06-124LENZ Therapeutics, Inc. (LENZ)
jointly with Versant Venture Capital VI, L.P., Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage II, L.P., Versant Vantage II GP, L.P., Versant Vantage II GP-GP, LLC, Versant Venture Capital VII, L.P., Versant Ventures VII GP-GP, LLC
Sale (S): 350,000 @ $29EDGAR
2024-03-254LENZ Therapeutics, Inc. (LENZ)
jointly with Versant Venture Capital VI, L.P., Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage II, L.P., Versant Vantage II GP, L.P., Versant Vantage II GP-GP, LLC, Versant Venture Capital VII, L.P., Versant Ventures VII GP-GP, LLC
Other (J): 598,203EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1777655 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs